Health

Congresswoman Maloney understands that the health of her constituents and all American citizens has to be prioritized for the country to grow and thrive.

Affordable Care Act and Health Care: All American citizens deserve to have access to good and affordable health care. Thanks to the Patient Protection and Affordable Care Act, millions more Americans are able to secure affordable, quality and accessible health care. Signed into law in 2010, Americans of all ages are already seeing expanded health insurance coverage and cost savings. Congresswoman Maloney is a proud supporter of this historic law that makes for a healthier America and strengthens the country’s economic security. Read more.

Funding for the National Institutes of Health: The National Institutes of Health is responsible for cutting edge research to develop novel, innovative, and ground-breaking medicine and technology that can cure diseases like Parkinson’s, spinal cord injuries and organ failure. Congresswoman Maloney is a strong supporter of federal funding for NIH research to allow researchers at NIH to continue their life-saving work.

Parkinson’s Disease: Parkinson’s disease is one of the many diseases Congresswoman Maloney hopes will reap the benefits of federally funded medical research. The Congresswoman has worked hard to combat Parkinson’s disease by fighting for federal funding to support research on the disease, as well as by increasing public awareness about the challenges faced by millions of Americans suffering from Parkinson’s. Read More.

Skin Cancer Prevention: In 2007, Congresswoman Maloney introduced the Tanning Accountability and Notification (TAN) Act, which required the Food and Drug Administration to determine whether the current labeling of indoor tanning beds provides sufficient information about the risks associated with indoor tanning. Read more.

Vaccines: Congresswoman Maloney believes that vaccines are safe, effective, and absolutely essential for public health by preventing the suffering and costs of infectious diseases, and has been continually supportive of programs and legislation that would ensure people have access to vaccines both at home and abroad. She has and continues to work with her colleagues to combat misinformation about vaccines and encourages all families to follow the guidance of their doctors. Read more.

For other legislation and related documents click here.

More on Health

Jun 11, 2021 Press Release

WASHINGTON, DC — Today, ahead of the 5 year anniversary of the Pulse Nightclub shooting in Orlando, Florida, Congresswoman Carolyn B. Maloney (D-NY) joined with Reps. Val B. Demings (D-FL), Mike Quigley (D-IL), Adam B. Schiff (D-CA), Barbara Lee (D-CA), and Ritchie Torres (D-NY) in sending a letter to U.S. Food and Drug Administration (FDA) Acting Commissioner Dr.

May 26, 2021 In The News

Pharmaceutical giant AbbVie inflated prices for widely-used drugs while its executives pocketed growing bonuses, according to a new report from the House Oversight and Reform Committee. Now it's helping fund ads attacking legislation that would lower prescription drug costs.

May 19, 2021 In The News

As Emergent BioSolution's Baltimore factory was throwing away unfinished COVID-19 vaccine doses and struggling to pass muster with the Food and Drug Administration, the company awarded at least $3 million in bonuses to a handful of executives, according to documents released by a congressional subcommittee Wednesday.

May 19, 2021 In The News

Johnson & Johnson documented serious contamination risks at a troubled Baltimore biodefense plant in June 2020, seven months before a contamination incident ruined 15 million doses of coronavirus vaccine and derailed Johnson & Johnson’s domestic vaccine production, according to documents disclosed Wednesday by a House panel investigating the incident.

May 19, 2021 In The News

The chief executive of Emergent BioSolutions, whose Baltimore plant ruined millions of coronavirus vaccine doses, disclosed for the first time on Wednesday that more than 100 million doses of Johnson & Johnson’s vaccine are now on hold as regulators check them for possible contamination.

May 19, 2021 In The News

In the face of a sprawling congressional inquiry and sustained scrutiny over its handling of a contract to help develop coronavirus vaccines, an executive of the beleaguered biotech firm Emergent BioSolutions told lawmakers on Wednesday that he hopes to resume vaccine production "in the coming days," pending FDA sign off.

May 18, 2021 In The News

Three House Democrats called on the Federal Trade Commission (FTC) to investigate drugmaker AbbVie for its pricing of Humira, the best-selling drug in the U.S. and internationally. 

May 18, 2021 In The News

WASHINGTON — Pharmaceutical company AbbVie significantly inflated prices over the past two decades for patients in the U.S. who take the drugs Humira and Imbruvica, a report released Tuesday by the House Oversight and Reform Committee found.

The committee concluded that the price increases led to billions of dollars in corporate revenue and hefty bonuses for company executives.

May 18, 2021 In The News

A group of mostly Democratic House lawmakers pressed drugmaker AbbVie’s CEO on Tuesday over the increased prices of anti-inflammatory drug Humira and cancer drug Imbruvica in the U.S. in the years since they first became available.  

AbbVie's Richard Gonzalez faced tough questions from the Oversight and Reform Committee, with Democrats accusing the company of taking advantage of patients and the health care system to charge more for medicine and bring in billions of dollars for revenue and executive bonuses. 

May 6, 2021 In The News

Lawmakers pushing to address the nation’s rising maternal death rate — particularly among Black women — heard testimony Thursday on what Congress can do to address the problem